A multivalent biparatopic EGFR-targeting nanobody drug conjugate displays potent anticancer activity in solid tumor models.
Jiansheng FanXinlei ZhuangXiaoyue YangYingchun XuZhan ZhouLiqiang PanShuqing ChenPublished in: Signal transduction and targeted therapy (2021)